Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice

AIDS Read. 2009 Mar;19(3):118-9.

Authors

Mohamed G Atta¹, Derek M Fine

Affiliation

¹ Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

PMID: 19334329

No abstract available

Publication types

Comment
Editorial

MeSH terms

Adenine / adverse effects
Adenine / analogs & derivatives*
Anti-HIV Agents / adverse effects*
Clinical Trials as Topic
Diabetes Insipidus / chemically induced
Didanosine / adverse effects
Drug Therapy, Combination
Fanconi Syndrome / chemically induced*
HIV Infections / drug therapy*
Humans
Kidney Function Tests
Male
Organophosphonates / adverse effects*
Reverse Transcriptase Inhibitors / adverse effects*
Risk Factors
Tenofovir

Substances

Anti-HIV Agents
Organophosphonates
Reverse Transcriptase Inhibitors
Tenofovir
Adenine
Didanosine